However, these T cells with high expressions of PDCD1 and CTLA4 are almost absent in a significant number of patients with AM, which may make the patients unresponsive to immune checkpoint suppression therapy. This evidence concerns the gene CTLA4 and acute myeloblastic leukemia with maturation.